Key Record Dates
ClinicalTrials.gov Identifier: | NCT03454451 |
---|---|
Brief Title: | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers |
First Submitted : | February 5, 2018 |
First Submitted that Met QC Criteria : | March 2, 2018 |
First Posted : | March 6, 2018 |
Last Update Submitted that Met QC Criteria : | August 1, 2022 |
Last Update Posted : | August 3, 2022 |